Novavax (NVAX) Change in Acquisitions & Divestments (2010 - 2026)

Novavax's Change in Acquisitions & Divestments history runs 15 years deep, the most recent figure standing at $147.3 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments rose 242.53% year-over-year to $147.3 million; the TTM figure through Mar 2026 stood at $458.0 million (down 5.86% YoY), while the FY2025 annual figure was $353.7 million, down 20.25% from the prior year.
• Change in Acquisitions & Divestments was $147.3 million for Q1 2026 at Novavax, up from $98.6 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $337.9 million in Q4 2024 to a low of $43.0 million in Q1 2025.
• Historically, Change in Acquisitions & Divestments has averaged $134.9 million across 3 years, with a median of $105.6 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Change in Acquisitions & Divestments sank 70.82% in 2025, then jumped 242.53% in 2026.
• A 3-year view of Change in Acquisitions & Divestments shows it stood at $337.9 million in 2024, then plunged by 70.82% to $98.6 million in 2025, then jumped by 49.37% to $147.3 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $147.3 million (Q1 2026), $98.6 million (Q4 2025), and $100.5 million (Q3 2025), per Business Quant data.